First World Congress on
Mitochondria and Microbiota: Crucial Impact
Targeting EVs 2024 Highlights
The First World Conference Targeting EVs, held on October 17-18, 2024, at the Corinthia Palace in Malta, was a remarkable success. Attendees from over 27 countries gathered to share insights, with more than 40 communications delivered.
Pictures from the congress will be available soon. In the meantime, check out some highlights on our LinkedIn page.
Discussions will revolve around the dual role of EVs in mitochondrial function. They are instrumental in optimizing mitochondrial function by transferring proteins and genetic materials, which is vital for targeted drug delivery. However, they also pose risks by spreading damaged mitochondrial components, contributing to disease progression. The latest research in this field aims at biomarker discovery and regenerative approaches in mitochondrial medicine.
This segment will focus on microbiota-derived EVs and their significant role in health and disease. They facilitate communication among microorganisms and influence host cells, serving as potential biomarkers. These interactions between host-derived EVs and the microbiota offer promising therapeutic strategies for immune modulation, microbial balance restoration, and treating microbiota-related diseases.
Targeting EVs 2024 Program
Abstracts Book and VOD of Targeting EVs 2024
If you were not able to attend the congress online or in-person, the abstracts book and Video of All Presentations of Targeting EVs 2024 are now available for purchase.
The edition of Targeting EVs digital abstracts book compiles 40+ abstracts: from major talks to short oral and poster presentations. It also includes speaker details and emails for direct connections.
Speakers Line-Up
Role of Stem Cell-Derived Extracellular Vesicles to Promote Successful Aging
Consuelo Borrás, University of Valencia, Spain
Extracellular Vesicle Release of Mitochondria in Response to Lysosomal Dysfunction
Åsa B. Gustafsson, University of California San Diego, USA
Liposomes & Exosomes: Lessons & Perspectives
Volkmar Weissig, Midwestern University, College of Pharmacy Glendale, USA
Delivery of Mitochondria-Containing EVs to the Blood-Brain Barrier
Devika S. Manickam, Duquesne University, USA
The Role of Mitovesicles in the Brain with Mitochondrial Dysfunction
Efrat Levy, NYU Grossman School of Medicine, USA
Microbiota-Derived Extracellular Vesicles in Maternal-Fetal Communication: What We Know?
Justus Reunanen, University of Oulu, Finland
Engineering Exosomes for Precise Mitochondrial Targeting in Brain Cells: Expanding the Frontiers of Cellular Communication and Therapeutics
Lanrong Bi, Michigan Technological University, USA
Mitochondrial DAMPs in EVs: Triggering Early Neuroinflammation in Neurodegeneration
Carla Lopes, University of Coimbra, Portugal
Therapeutic Applications of Microbial Extracellular Vesicles
Steven Jay, University of Maryland, USA
Targeting central regulation of obesity with EVs: Breakthrough Approach Nature Metabolism
Ramaroson Andriantsitohaina, University of Montpellier, France
Exploring the Capabilities of Exosomes from Muscle-Derived Mesenchymal Stem Cells: Insights into Immunomodulation and Mitochondrial Transfer
Didier Serteyn, Université de Liège, Belgium
Cancer-related Extracellular Vesicles in relation to Mitochondria, Microbiota and More
Lorraine O’Driscoll, Trinity College Dublin and Trinity St. James's Cancer Institute, Ireland
Bioinspired, Fully Synthetic Extracellular Vesicles to Optimize Wound Healing
Joachim Pius Spatz, University of Heidelberg, Germany
Modulation of Phage-Microbe interactions and Antimicrobial Resistance by Bacterial Extracellular Vesicles
Meta Kuehn, Duke University, USA
Lactobacilli Extracellular Vesicles: Potential Postbiotics to Support The Vaginal Microbiota Homeostasis
Carola Parolin, University of Bologna, Italy
Gut-Microbiome Derived Extracellular Vesicles in Cancer
Surbhi Mishra, University of Oulu, Finland
The gut microbe-derived extracellular vesicles (GMEVs)- mitochondria axis in mental disorders: Strengths and weaknesses of new studies
Seyed Davar Siadat, Pasteur Institute of Iran, Iran
Who is attending the First Targeting EVs 2024 Congress ?
l’Oreal
Lallemand Animal Nutrition
GPS-PAR Inv e Part Ltda
Midra BV
Dr safavi clinic
Probiotical Research Srl
Amsterdam Vesicle Center
Amsterdam UMC
AOP Health
Asan Medical Center
Bonn-Rhine-Sieg Universtiy of Applied Sciences
Medical University of Innsbruck
Escuela de Medicina Instituto Tecnologico y de Estudios Superiores de Monterrey
Fundació Institut d’Investigació Sanitària Pere Virgili
German Diabetes Center (DDZ)
HNO-Klinik Innsbruck
Hospital Virgen Del Rocio
International Flavors and Fragrances (IFF)
Institut Curie
Institute for Biomedical Aging Research
National Taiwan University
John Hopkins
Lithuanian University of Health Sciences
Marshall University
Masaryk Memorial Cancer Institute
Medical University of Warsaw
Metabolomics Platform
Michigan Technological University
National Research center Kurchatov Institute
NYU Grossman School of Medicine
Ohio State University
Pasteur Institute of Iran
Lithuanian University of Health Sciences
SUNY University at Buffalo
Trinity College Dublin and Trinity St. James’s Cancer Institute
University of Angers
University of Bologna
University of Bergen
University of California San Diego
University of Groningen
University of Heidelberg
University of Innsbruck
University of Innsbruck
Università di Pisa
University of Maryland
University of Milan
University of Oulu
University of Valencia
Utrecht University
